Echocardiography–fluoroscopy fusion imaging: The essential features used in congenital and structural heart disease interventional guidance

2020 ◽  
Vol 37 (5) ◽  
pp. 769-780 ◽  
Author(s):  
Pei‐Ni Jone ◽  
Juan Pablo Sandoval ◽  
Alexander Haak ◽  
Jacob Hammers ◽  
Hugo Rodriguez‐Zanella ◽  
...  
Keyword(s):  
Heart Disease ◽  
Structural Heart Disease ◽  
Fusion Imaging ◽  
Interventional Guidance

scholarly journals Echocardiography-Fluoroscopy Fusion Imaging for Guidance of Congenital and Structural Heart Disease Interventions

2019 ◽  
Vol 12 (7) ◽  
pp. 1279-1282 ◽  
Author(s):  
Pei-Ni Jone ◽  
Alexander Haak ◽  
Nils Petri ◽  
Michael Ross ◽  
Gareth Morgan ◽  
...  
Keyword(s):  
Heart Disease ◽  
Structural Heart Disease ◽  
Fusion Imaging

Echocardiography in the cath lab: Fusion imaging and use of intracardiac echocardiography

2021 ◽  
pp. 121-128
Author(s):  
Covadonga Fernández-Golfín ◽  
José Luis Zamorano
Keyword(s):  
Heart Disease ◽  
Structural Heart Disease ◽  
Transoesophageal Echocardiography ◽  
Fusion Imaging ◽  
Intracardiac Echocardiography ◽  
Imaging Modalities ◽  
Fusion System ◽  
Basic Principles ◽  
Fused Image

Structural heart disease interventions represent a new branch of percutaneous treatments rapidly expanding. Imaging, mainly transoesophageal echocardiography is essential to guide the procedures along with fluoroscopy. In the last year, fusion of both imaging modalities is available with dedicated software that allows the visualization of both echo and fluoro in a single fused image. These systems allow a better anatomic depiction of the different structures allowing safer and faster procedures with a better communication between the interventionalists and the imagers. In this chapter we will review the basic principles of these fusion system and main uses as well as the role of intracardiac echocardiography in the cath lab.

Congenital and Structural Heart Disease Interventions Using Echocardiography-Fluoroscopy Fusion Imaging

2019 ◽  
Vol 32 (12) ◽  
pp. 1495-1504 ◽  
Author(s):  
Pei-Ni Jone ◽  
Alexander Haak ◽  
Michael Ross ◽  
Dominik M. Wiktor ◽  
Edward Gill ◽  
...  
Keyword(s):  
Heart Disease ◽  
Structural Heart Disease ◽  
Fusion Imaging

X-Ray-Echo Fusion Imaging in Catheter-Based Structural Heart Disease Interventions

2019 ◽  
pp. 351-362
Author(s):  
Francesco Fulvio Faletra ◽  
Giovanni Pedrazzini ◽  
Elena Pasotti ◽  
Marco Moccetti ◽  
Tiziano Moccetti ◽  
...  
Keyword(s):  
Heart Disease ◽  
Structural Heart Disease ◽  
Fusion Imaging ◽  
X Ray

scholarly journals Usefulness of echocardiographic-fluoroscopic fusion imaging in adult structural heart disease

2018 ◽  
Vol 111 (6-7) ◽  
pp. 441-448 ◽  
Author(s):  
Julien Ternacle ◽  
Romain Gallet ◽  
Annabelle Nguyen ◽  
Jean-François Deux ◽  
Antonio Fiore ◽  
...  
Keyword(s):  
Heart Disease ◽  
Structural Heart Disease ◽  
Fusion Imaging

Fusion Imaging for Structural Heart Disease Interventions

2017 ◽  
Vol 10 (12) ◽  
Author(s):  
Craig Basman ◽  
Yuvrajsinh J. Parmar ◽  
Chad Kliger ◽  
Vladimir Jelnin ◽  
Tilak K. R. Pasala ◽  
...  
Keyword(s):  
Heart Disease ◽  
Structural Heart Disease ◽  
Fusion Imaging

Identification of High-risk Patients for Implantable Cardioverter–Defibrillator Therapy in Asia

2011 ◽  
Vol 3 (1) ◽  
pp. 77
Author(s):  
Cyril YK Ko ◽  
Jeffrey WH Fung ◽  
◽  
Keyword(s):  
Heart Disease ◽  
Implantable Cardioverter Defibrillator ◽  
Asian Population ◽  
Structural Heart Disease ◽  
Medical Problem ◽  
Western World ◽  
Asian Countries ◽  
Cardioverter Defibrillator ◽  
Asian Patients ◽  
Risk Patients

Sudden cardiac death (SCD) is a serious medical problem worldwide. Multiple landmark studies have demonstrated the benefit of implantable cardioverter–defibrillator (ICD) therapy in preventing SCD in at-risk patients. Although the data available in Asia are limited, the disease pattern seems to be different from that in the western world. The Asian population seems to have a lower incidence of SCD. Coronary heart disease, which is the major underlying cause of SCD in the west, may play a less important role in Asian countries. In addition, non-structural heart disease seems to be a more prevalent cause of SCD in Asia. It is thus questionable whether the results of ICD trials can be applied directly to Asian countries, as most of these trials seldom recruited Asian patients. This article will review SCD in Asia, focusing on the epidemiology and risk factors for SCD in Asia and highlighting some unique features that may be different from those seen in the western world.

Sign in / Sign up

Export Citation Format

Share Document